Concepedia

Jessie Bourcier

JB

Statistics

Publications

10

Citations

511

H-Index

10

Active since

1994

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Centre Hospitalier Universitaire de Nantes

University of Miami

Sylvester Comprehensive Cancer Center

Kettering University

Jessie Bourcier is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, oncology, and molecular oncology.

ORCID

Publications per year

1994–2024

10

Publications

10

Kinase-impaired BTK mutations are susceptible to clinical-stage BTK and IKZF1/3 degrader NX-2127

Skye Montoya, Jessie Bourcier, Mark Noviski et al. · Science · 2024 · 148 citations · Full text

, , +15

Modulation of RNA splicing enhances response to BCL2 inhibition in leukemia

Eric Wang, Jose Mario Bello Pineda, Won Jun Kim et al. · Cancer Cell · 2022 · 77 citations · Full text

, , +17

BH3-mimetic toolkit guides the respective use of BCL2 and MCL1 BH3-mimetics in myeloma treatment

Patricia Gomez‐Bougie, Sophie Maïga, Benoît Tessoulin et al. · Blood · 2018 · 76 citations · Full text

, , +15

Prevalence of the reversed halo sign in neutropenic patients compared with non‐neutropenic patients: Data from a single‐centre study involving 27 patients with pulmonary mucormycosis (2003‐2016)

Jessie Bourcier, Pierre‐Marie Heudes, Florent Morio et al. · Mycoses · 2017 · 51 citations

, , +13

E7820, an anti-cancer sulfonamide, degrades RBM39 in patients with splicing factor mutant myeloid malignancies: a phase II clinical trial

Jan Philipp Bewersdorf, Maximilian Stahl, Justin Taylor et al. · Leukemia · 2023 · 50 citations · Full text

, , +8

1–5 of 10